Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
The majority of COVID-19 cases are only mildly or moderately symptomatic, but in some patients excessive inflammatory response becomes the dominant factor of disease progression to the advanced stage, with high mortality. Treatment with anti-inflammatory drugs either does not prevent disease progres...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2021-06-01
|
| Series: | Folia Neuropathologica |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Are-central-nervous-system-drugs-displaying-anti-inflammatory-r-nactivity-suitable-for-early-treatment-of-COVID-19-,20,44630,1,1.html |